Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reiss

Showing results (241-250 of 270) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.
IJTLD Open|April 24, 2024
Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TBP S Rao, K Reed, N Modi, et al.
Ophthalmology and Therapy|March 25, 2025
Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY StudyIqbal Ike K Ahmed, John P Berdahl, Arkadiy Yadgarov, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activityDong-Mei Feng, Robert M DiPardo, Jenny M Wai, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Radiation Research|January 14, 2009
The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: I. Study methodsA Romanenko, V Bebeshko, M Hatch, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Pageof 27

Showing results (241-250 of 270) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.
IJTLD Open|April 24, 2024
Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TBP S Rao, K Reed, N Modi, et al.
Ophthalmology and Therapy|March 25, 2025
Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY StudyIqbal Ike K Ahmed, John P Berdahl, Arkadiy Yadgarov, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activityDong-Mei Feng, Robert M DiPardo, Jenny M Wai, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Radiation Research|January 14, 2009
The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: I. Study methodsA Romanenko, V Bebeshko, M Hatch, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Pageof 27